45 results about "Mannitol Injection" patented technology

The invention discloses a thermal insulation device for water-bath heating and dissolving of mannitol. The thermal insulation device comprises a heating box and a thermal insulation box, wherein a thermal-protective coating is arranged between the heating box and the thermal insulation box; the heating box and the thermal insulation box comprise box bodies and box covers; box body walls and the box covers structurally comprise housings, thermal insulation layers and water-resisting layers; a heating device is arranged above the thermal insulation layer inside each box body and is connected with a temperature controller; a filter net is arranged inside each box body; a vertical lead rail is also arranged at the inner side of each water-resisting layer; a bump matched with the corresponding lead rail is arranged on the edge of each filter net; a filter net crank is arranged on the outer side of each box body, and controls the corresponding filter net to slide up and down along the corresponding lead rail through a cam device; a heat-conducting coil is also arranged on the bottom of the thermal insulation box; a water inlet and a water outlet of the heat-conducting coil are formed inside the heating box; a miniature temperature control electric pump is arranged at the water inlet section of the heat-conducting coil inside the thermal insulation box, and connected with the temperature controller. The device can be used for heating and constantly keeping warm, the problems that mannitol injection is not easy to inject at low temperature or high temperature are solved, and the thermal insulation device has an energy-saving effect, and is convenient to use, low in manufacturing and use costs, and convenient to popularize and use.

The invention relates to the technical field of pharmaceutic preparations, in particular to a mannitol injection. The mannitol injection is prepared from, by weight, 14%-20% of mannitol, 3%-9% of olive oil, 1%-7% of tween 80 and the balance of water for injection. According to the mannitol injection, the curative effect is good, crystals do not occur at low temperature, the use safety is high, and the phenomena of allergies and hemolysis do not occur.

The invention relates to the technical field of medicinal preparations, in particular to a mannitol injection. The mannitol injection is prepared from the following raw materials in percentage by weight: 12 to 19 percent of mannitol, 0.5 to 1.3 percent of a jasmine extract, 0.8 to 1.6 percent of a pseudo-ginseng extract, and the balance of injection water, and the total percent is 100. Compared with the prior art, the mannitol injection provided by the invention has a good treatment effect and a good effect on treating high intracranial pressure caused by cerebral hemorrhage, does not crystallize at a low temperature, and is high in use safety and convenient to use clinically; hypersensitivity is avoided; adverse reactions, such as an infusion reaction, are remarkably reduced.

The invention relates to the technical field of pharmaceutical preparations, in particular to a compound mannitol injection, which is made of the following raw materials in percentage by weight: mannitol 6-10%, sorbitol 3-9%, Tween 80 1-6%, olive Add 1-5% oil, 0.4-0.6% sodium chloride, and water for injection to 100%. The compound mannitol injection of the invention has good curative effect, no crystallization at low temperature, high use safety, no allergy phenomenon, convenient clinical use, and significantly reduces adverse reactions such as infusion reactions.

The invention discloses eye drops for resisting asthenopia. The eye drops comprise the following components: amiotide eye drops, inosine injection, adenosine disodium triphosphate injection, racanisodamine injection, vitamin B6 injection, taurine eye drops and an assistant for eyes, wherein the assistant for eyes is at least one of injection water or an isoosmotic adjusting agent; the isoosmotic adjusting agent is at least one of a sodium chloride physiological saline, glucose injection, sorbitol eye drops, borate saline buffer, mannitol injection or polyethylene glycol eye drops. The invention also discloses a preparation method of the eye drops for resisting asthenopia. The eye drops have the advantages that: 1, the overall efficacy of a compound preparation is obviously superior to a single drug effect; 2, the eye drops play roles in the whole process of the disease, the dose is reduced, and the side effect is reduced; 3, various medicines work in coordination with each other, are complementary in efficacy, and are taken as preconditions for playing roles; 4, the eye drops are obvious in pharmacological effect, applicable and convenient, and convenient to carry.

The invention discloses an application of mannitol in preparation of an anti-stomach cancer drug, and in particular relates to a use of a mannitol injection with a specific concentration of 10%-19% for treating stomach cancer. Traditionally, mannitol is only used as a diuretic, a high-permeability hypotensor and the like, while the inventor discovers through scientific experiments that mannitol has anti-tumor activity, and through several cell apoptosis detection technologies and by detecting apoptosis-related genes bcl-2, and bax, proves that the specific-concentration mannitol can induce various human cancer cell strains to generate obvious cancer cell apoptosis, grasps the effect relation with concentration and time, and first illustrates the possible mechanism; furthermore, the inventor has used the research result for tumor patient treatment and has achieved obvious curative effect, which provides theoretical basis and practical cases for the application of mannitol in the preparation of the anti-tumor drug and the clinical generalization thereof.

The invention discloses an intestinal flora reestablishment kit. The kit comprises a kit body; the kit body comprises multiple cavities which are sequentially and regularly opened, the cavities are from the n th cavity to the (n+x) th cavity according to the opening sequence, and the time interval of opening time of adjacent cavities from the n th cavity to the (n+x) th cavity is 4-12 h; the n thcavity comprises compound polyethylene glycol electrolyte powder or mannitol injection, the (n+1) th cavity comprises A and B microecologics, the (n+2) th cavity comprises B microecologics, the cavities from the (n+3) th cavity to the (n+21) th cavity comprise B and A microecologics, and the cavities from the (n+22) th cavity to the (n+x) th cavity comprise B microecologics. Through intestinal lavage and sequential taking of different preparations, quick reestablishment of the intestinal flora is facilitated. The invention further discloses application of the kit to reestablishment of ankylosing spondylitis and rheumatoid intestinal florae. Through the reestablishment of the intestinal flora, arthralgia of a patient is relieved, joints move freely, so that the kit is feasible in the aspectof relieving arthralgia and discomfort of the patient.

The invention discloses an injectable drug for treating varicosity, and the drug is prepared by mixing medical mannitol injection with dextrose injection according to a weight ratio of 15:5. The drug disclosed by the invention is injected to local diseased vein, acts on the inside part of the diseased blood vessel and activates the blood vessel to form aseptic inflammation so as to implement fibrillation of the tissues, close the blood vessel and improve blood circulation of legs, no destructive effect is caused to the function of the body, all cirsoid veins are retracted 10 days later, the skin is smooth as before and varicosity never recurs. The drug disclosed by the invention is widely used by people, stable in curative effect, low in cost and free of toxic and side effects. So far, thousands of clinically cured patients never suffer from varicosity again; the drug is low in cost and is only 1 / 4 of the surgery cost; the patients feel no pain and are easy to accept the drug, so the drug obtains good social benefit and economic benefit.

The invention relates to a device for preventing mannitol injection from crystallizing. The device comprises a mannitol thermotank, pin caps, and hinge movable rods, sliding groove rods are formed inthe two sides of the mannitol thermotank, clamping grooves are connected to the inner sides of the sliding groove rods, a bearing frame is mounted on the inner sides of the clamping grooves, the two sides of the outer portion of the mannitol thermotank are connected with closing doors, hinge columns are arranged on one sides of the interiors of the closing doors, a ventilation frame is connected with the top end of the interior of the mannitol thermotank, the top end of the ventilation frame is provided with a top cover frame, the top end of the bearing frame is provided with a mannitol bottleplacing frame, and the bottom end of the ventilation frame is connected with an active carbon layer frame. The device has the beneficial effects that a user can push the active carbon layer frame todrive a sliding block to do lifting motion along the position between the sliding groove rods, the active carbon layer frame can be effectively lifted to be isolated between storage frames, peculiar smell between walls of the mannitol thermotank can be absorbed between layers of the active carbon layer frame, and the peculiar smell of the mannitol thermotank can be purified.

The invention relates to the field of pharmaceutical preparations and particularly relates to a mannitol injection. The mannitol injection is prepared from mannitol, glycine, lecithin and water for injection, wherein the weight ratio of mannitol to glycine to lecithin is 10:3:1.

The invention discloses an intestinal flora reestablishment kit. The kit comprises a kit body; the kit body comprises multiple cavities which are sequentially and regularly opened, the cavities are from the n th cavity to the (n+x) th cavity according to the opening sequence, and the time interval of opening time of adjacent cavities from the n th cavity to the (n+x) th cavity is 4-12 h; the n thcavity comprises compound polyethylene glycol electrolyte powder or mannitol injection, the (n+1) th cavity comprises A and B microecologics, the (n+2) th cavity comprises B microecologics, the cavities from the (n+3) th cavity to the (n+21) th cavity comprise B and A microecologics, and the cavities from the (n+22) th cavity to the (n+x) th cavity comprise B microecologics. Through intestinal lavage and sequential taking of different preparations, quick reestablishment of the intestinal flora is facilitated. The invention further discloses application of the kit to reestablishment of ankylosing spondylitis and rheumatoid intestinal florae. Through the reestablishment of the intestinal flora, arthralgia of a patient is relieved, joints move freely, so that the kit is feasible in the aspectof relieving arthralgia and discomfort of the patient.

The invention relates to a production and preparation process capable of lowering mannitol injection crystallization. The production and preparation process is characterized in that material preparation is operated under Grade-B environment conditions under a background Grade-C, and raw materials are enabled to pass a 200-mesh screen, namely a screen of 75um+ / -4.1um; a super filter element terminal of 0.1um is adopted for filtering; a preparation method of a PH value adjuster includes: weighing 180ml of concentrated hydrochloric acid, adding water for injection to 1000ml, shaking well, and using a filter membrane of 0.1um to perform suction filtering to obtain a hydrochloric acid adjuster of 2mol / L; a PH value adjusting method includes: weighing 2mol / L hydrochloric acid in a needed amount, pouring into a clean measuring cup, linearly adding into a diluting tank while stirring, and stirring well; 90-100 DEG C is determined as using temperature of the water for injection, number of intensive washing times is 10 times of flushing, and water pressure for flushing each time is not lower than 0.15Mpa. By the production and preparation process, proportion of mannitol crystallization during selling is lowered, and high-quality products are provided for clinical medication.